Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Organic crystal structure prediction (CSP) studies have led to the rapid development of methods for predicting the relative energies of known and computer-generated crystal structures. There is a compromise between the level of theoretical treatment, its reliability across different types of organic systems, how its accuracy depends on the size and shape of the unit cell, and the size and the number of structures that can be modeled at an affordable computational cost. We have used our database of crystal structure prediction studies, often performed as a complement to experimental screening, to produce sets comprising 6 to 15 crystal structures, covering known polymorphs, observed packings of closely related molecules, and CSP-generated energetically competitive but distinct structures, for 20 organic molecules. These have been chosen to illustrate some of the issues that need consideration in any lattice energy method, seeking to be generally applicable to moderate-sized organic molecules, including small drug molecules. We included the methods of crystallization reported for the experimental polymorphs. In all of the examples, the original CSP used electronic structure calculations on the molecule to give the conformational energy and an anisotropic atom-atom model for the electrostatic intermolecular energy, combined with an empirical "exp-6" repulsion dispersion model to give the intermolecular lattice energy. The lattice energies and structures are compared with those obtained by reoptimizing with periodic, plane-wave, dispersion-corrected density functional theory, specifically PBE with the TS dispersion correction, and with single point energies where the many body dispersion (MBD) dispersion correction is applied, as an example of a widely used "workhorse" method. The use of this data set for a preliminary test of modeling methods is illustrated for two Machine Learned Foundation Models, MACE-MP-0 and MACE-OFF23. The challenges in modeling the putative and observed polymorphs for a range of molecules, their energies, and the possible level of agreement with experimental data are illustrated. Very similar molecules can differ significantly in the polymorphs observed, only partially reflecting the range of polymorph screening experiments used and the energetically competitive structures produced by CSP approaches based on a purely thermodynamic paradigm.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12063060PMC
http://dx.doi.org/10.1021/acs.cgd.5c00255DOI Listing

Publication Analysis

Top Keywords

data set
8
modeling methods
8
crystal structure
8
structure prediction
8
crystal structures
8
polymorphs observed
8
energetically competitive
8
organic molecules
8
lattice energy
8
dispersion correction
8

Similar Publications

The transition from traditional animal-based approaches and assessments to New Approach Methodologies (NAMs) marks a scientific revolution in regulatory toxicology, with the potential of enhancing human and environmental protection. However, implementing the effective use of NAMs in regulatory toxicology has proven to be challenging, and so far, efforts to facilitate this change frequently focus on singular technical, psychological or economic inhibitors. This article takes a system-thinking approach to these challenges, a holistic framework for describing interactive relationships between the components of a system of interest.

View Article and Find Full Text PDF

Background And Purpose: Low-level light therapy (LLLT) has been shown to modulate recovery in patients with traumatic brain injury (TBI). However, the longitudinal impact of LLLT on brain metabolites has not been studied. The purpose of this study was to use magnetic resonance spectroscopic imaging (MRSI) to assess the metabolic response of LLLT in patients with moderate TBI at acute (within 1 week), subacute (2-3 weeks), and late-subacute (3 months) recovery phases.

View Article and Find Full Text PDF

Gepotidacin, a novel, bactericidal, first-in-class triazaacenaphthylene antibacterial, was noninferior to nitrofurantoin in two pivotal trials (EAGLE-2 and EAGLE-3) in females with uncomplicated urinary tract infections (uUTIs). Using pooled data, gepotidacin activity and clinical efficacy were evaluated for subsets of molecularly characterized isolates in the microbiological Intent-to-Treat population. The subsets of isolates were characterized based on phenotypic/MIC criteria; all microbiological failure isolates were also characterized.

View Article and Find Full Text PDF

How many (distinguishable) classes can we identify in single-particle analysis?

Acta Crystallogr D Struct Biol

October 2025

Centro Nacional de Biotecnologia-CSIC, Calle Darwin 3, 28049 Cantoblanco, Madrid, Spain.

Heterogeneity in cryoEM is essential for capturing the structural variability of macromolecules, reflecting their functional states and biological significance. However, estimating heterogeneity remains challenging due to particle misclassification and algorithmic biases, which can lead to reconstructions that blend distinct conformations or fail to resolve subtle differences. Furthermore, the low signal-to-noise ratio inherent in cryo-EM data makes it nearly impossible to detect minute structural changes, as noise often obscures subtle variations in macromolecular projections.

View Article and Find Full Text PDF

We describe the rationale, methodology, and design of the Boston University Alzheimer's Disease Research Center (BU ADRC) Clinical Core (CC). The CC characterizes a longitudinal cohort of participants with/without brain trauma to characterize the clinical presentation, biomarker profiles, and risk factors of post-traumatic Alzheimer's disease (AD) and AD-related dementias (ADRD), including chronic traumatic encephalopathy (CTE). Participants complete assessments of traumatic brain injury (TBI) and repetitive head impacts (RHIs); annual Uniform Data Set (UDS) and supplementary evaluations; digital phenotyping; annual blood draw; magnetic resonance imaging (MRI) and lumbar puncture every 3 years; electroencephalogram (EEG); and amyloid and/or tau positron emission tomography (PET) on a subset.

View Article and Find Full Text PDF